Drug Shortage Report for HALOPERIDOL INJECTION
| Report ID | 163328 |
| Drug Identification Number | 02366010 |
| Brand name | HALOPERIDOL INJECTION |
| Common or Proper name | Haloperidol Injection |
| Company Name | OMEGA LABORATORIES LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | HALOPERIDOL |
| Strength(s) | 5MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
| Packaging size | 10 x 1mL vial / fiole |
| ATC code | N05AD |
| ATC description | ANTIPSYCHOTICS |
| Reason for shortage | Shortage of an inactive ingredient or component. |
| Anticipated start date | 2022-07-11 |
| Actual start date | 2022-07-07 |
| Estimated end date | 2022-08-25 |
| Actual end date | 2022-08-25 |
| Shortage status | Resolved |
| Updated date | 2022-08-26 |
| Company comments | Product is now available |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 11177 HAMON MONTREAL, QUEBEC CANADA H3M 3E4 |
| Company contact information | info@omegalaboratory.com - 1-800-363-0584 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v21 | 2022-08-25 | French | Compare |
| v22 | 2022-08-26 | English | Compare |